← All diseases Infectious diseases

Drug-resistant tuberculosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (60)Meta-analysis (18)Treatment guideline (2)Phase 3 study (14)Systematic review (13)Randomized controlled trial (13)Clinical trial (160)Review article (220)Early Study (Phase 1 or 2) (10)Case report (62)Laboratory or animal study (27)Commentary or editorial (27)Retracted publication (1) Studies currently recruiting participants only (23)

Filter

Publications and studies (1457)

• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Enniatin A1, A Natural Compound with Bactericidal Activity against Mycobacterium tuberculosis In Vitro. (2019/12/20) ♡
• Risk factors for tuberculous empyema in pleural tuberculosis patients. (2019/12/20) ♡
• [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in Ecuador—Loss to follow-up in patients treated for multidrug-resistant tuberculosis in Ecuador]. (2019/12/20) ♡
• 4-Aminobenzoic Acid Derivatives: Converting Folate Precursor to Antimicrobial and Cytotoxic Agents. (2019/12/19) ♡
• Insight into the biology of Mycobacterium mucogenicum and Mycobacterium neoaurum clade members. (2019/12/17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. IMPACT study on intervening with a manualised package to achieve treatment adherence in people with tuberculosis: protocol paper for a mixed-methods study, including a pilot randomised controlled trial. (2019/12/17) ♡
• Impact of multidrug-resistant tuberculosis and its medications on adverse maternal and perinatal outcomes: protocol for a systematic review and meta-analysis. (2019/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lessons from the first 6 years of an intervention-based field epidemiology training programme in Papua New Guinea, 2013-2018. (2019/12/15) ♡
• Novel base-initiated cascade reactions of hemiindigos to produce dipolar γ-carbolines and indole-fused pentacycles. (2019/12/13) ♡
• Nanoparticle-Based Biosensing Assay for Universally Accessible Low-Cost TB Detection with Comparable Sensitivity as Culture. (2019/12/13) ♡
• Coexistence of bla (NDM-1) and rmtC on a Transferrable Plasmid of a Novel ST192 Klebsiella aerogenes Clinical Isolate. (2019/12/13) ♡
• Resazurin microtitre plate assay and Sensititre® MycoTB for detection of Mycobacterium tuberculosis resistance in a high tuberculosis resistance setting. (2019/12/13) ♡
• Dose-related adverse events in South African patients prescribed clofazimine for drug-resistant tuberculosis. (2019/12/12) ♡
• Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month. (2019/12/12) ♡
• Thiostrepton: A Novel Therapeutic Drug Candidate for Mycobacterium abscessus Infection. (2019/12/10) ♡
• Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of Mycobacterium tuberculosis Associated With Pyrazinamide Resistance. (2019/12/10) ♡
• Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria. (2019/12/10) ♡
• Moving towards universal health coverage: Strengthening the evidence ecosystem for the South African health system. (2019/12/05) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tuberculosis research in South Africa over the past 30 years: From bench to bedside. (2019/12/05) ♡
• Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin Due to RNA Polymerase H451D/Y/R Mutations From Computational Perspective. (2019/12/03) ♡
• Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis. (2019/12/03) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates. (2019/12/01) ♡
• Extensively resistant tuberculosis, Colombia, 2006-2016. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Reactivation of latent tuberculosis infection induced by cabazitaxel in a patient with prostate cancer: A case report. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Circulation of M. tuberculosis Beijing genotype in Latin America and the Caribbean. (2019/12/01) ♡
• Performance of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Tuberculosis through Testing of Formalin-fixed Paraffin-embedded Tissues. (2019/12/01) ♡
• Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs. (2019/12/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis. (2019/12/01) ♡
• Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients. (2019/12/01) ♡
• Reducing urinary oxalate by simultaneous using Sankol herbal drop with oxalate-degrading bacteria. (2019/12/01) ♡
• Spoligotyping and drug sensitivity of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients in the Arsi Zone of southeastern Ethiopia. (2019/11/28) ♡
• Knowledge, Attitudes, and Prevention Practices of Drug Resistant Tuberculosis in the Eastern Cape Province, South Africa. (2019/11/25) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Not-for-profit to launch antibiotic against drug-resistant tuberculosis. (2019/11/15) ♡
• Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia. (2019/11/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Establishing the cascade of care for patients with tuberculous meningitis. (2019/11/13) ♡
• [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014]. (2019/11/10) ♡
• Phenotypic and genotypic characterization of levofloxacin- and moxifloxacin-resistant Mycobacterium tuberculosis clinical isolates in southern China. (2019/11/01) ♡
• [Antimicrobial resistance: it is a global crisis, "a slow tsunami"]. (2019/11/01) ♡
• The effect of anti-tuberculosis drugs therapy on mRNA efflux pump gene expression of Rv1250 in Mycobacterium tuberculosis collected from tuberculosis patients. (2019/10/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Severe disseminated tuberculosis in HIV-negative refugees. (2019/10/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. [Mutations conferring resistance to first-line anti-tuberculosis drugs in Peru: a systematic review of the literature]. (2019/10/01) ♡
• Reasons for the delay in the initiation of treatment and initial default among drug-resistant tuberculosis patients in Ahmedabad corporation area. (2019/10/01) ♡
• Tuberculosis treatment outcome in Thessaloniki, Greece - a single center study. (2019/10/01) ♡
• Bench, bed and beyond: Communication and responsibility in decentralised tuberculosis care. (2019/09/30) ♡
• Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Candida nivariensis, Isolated in a Teaching Hospital in Poland. (2019/09/01) ♡
• Predictors of time to sputum culture conversion in multi-drug-resistant tuberculosis and extensively drug-resistant tuberculosis in patients at Tshepong-Klerksdorp Hospital. (2019/08/26) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Treatment for extreme drug-resistant tuberculosis wins US government approval. (2019/08/14) ♡
• Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. (2019/08/01) ♡
• Diagnostic performance and impact of routinely implemented Xpert® MTB/RIF assay in a setting of high incidence of drug-resistant TB in Odessa Oblast, Ukraine. (2019/08/01) ♡
• Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan. (2019/08/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.